Related references
Note: Only part of the references are listed.In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
Nicholas T. Younger et al.
CANCER RESEARCH (2022)
Molecular Targets in Cholangiocarcinoma
Colm J. O'Rourke et al.
HEPATOLOGY (2021)
mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment
Michael S. Haas et al.
MOLECULAR CANCER RESEARCH (2021)
Expression and Role of Dickkopf-1 (Dkk1) in Tumors: From the Cells to the Patients
Guohua Zhu et al.
CANCER MANAGEMENT AND RESEARCH (2021)
A phase III study of futibatinib (TAS-120) versus gemcitabine-cisplatin (gem-cis) chemotherapy as first-line (1L) treatment for patients (pts) with advanced (adv) cholangiocarcinoma (CCA) harboring fibroblast growth factor receptor 2 (FGFR2) gene rearrangements (FOENIX-CCA3).
Mitesh J. Borad et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival.
Samuel J. Klempner et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The anti-DKK1 antibody DKN-01 as an immunomodulatory combination partner for the treatment of cancer
Jaclyn A. Wall et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer
Ilaria Betella et al.
GYNECOLOGIC ONCOLOGY (2020)
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer
Lipika Goyal et al.
CLINICAL CANCER RESEARCH (2020)
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer
David R. Wise et al.
JCO PRECISION ONCOLOGY (2020)
Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma)
Christopher D. Jakubowski et al.
CHINESE CLINICAL ONCOLOGY (2020)
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine
Lorenza Rimassa et al.
JOURNAL OF AUTOIMMUNITY (2019)
Medical treatment for cholangiocarcinoma
Jorge Adeva et al.
LIVER INTERNATIONAL (2019)
The tumour microenvironment and immune milieu of cholangiocarcinoma
Luca Fabris et al.
LIVER INTERNATIONAL (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival
Lu Wu et al.
WORLD JOURNAL OF SURGERY (2019)
LBA10_PRClarIDHy: A global, phase III, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation
G K Abou-Alfa et al.
ANNALS OF ONCOLOGY (2019)
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
Vincenzo Mazzaferro et al.
BRITISH JOURNAL OF CANCER (2019)
The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma
Massimiliano Cadamuro et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Plasticity of myeloid-derived suppressor cells in cancer
Evgenii Tcyganov et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Milind Javle et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology
Michael H. Kagey et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2016)
CKAP4 is a Dickkopf1 receptor and is involved in tumor progression
Hirokazu Kimura et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer
Lucia D'Amico et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Macrophage-derived extracellular vesicle-packaged WNTs rescue intestinal stem cells and enhance survival after radiation injury
Subhrajit Saha et al.
NATURE COMMUNICATIONS (2016)
Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines
Eric Kowarz et al.
BIOTECHNOLOGY JOURNAL (2015)
Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines
Eric Kowarz et al.
BIOTECHNOLOGY JOURNAL (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
Xin Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Regulatory T cells in cancer immunotherapy
Hiroyoshi Nishikawa et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery
Ruo-Yu Shi et al.
CANCER (2013)
Cholangiocarcinomas can originate from hepatocytes in mice
Biao Fan et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Structural Basis of Wnt Signaling Inhibition by Dickkopf Binding to LRP5/6
Victoria E. Ahn et al.
DEVELOPMENTAL CELL (2011)
Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
Diego F. Calvisi et al.
GASTROENTEROLOGY (2011)
Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
Kiavash Movahedi et al.
CANCER RESEARCH (2010)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A. Corzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
A Central Role for Induced Regulatory T Cells in Tolerance Induction in Experimental Colitis
Dipica Haribhai et al.
JOURNAL OF IMMUNOLOGY (2009)
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
Marcus C. B. Tan et al.
JOURNAL OF IMMUNOLOGY (2009)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor:: Influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells
Andrew G. Jarnicki et al.
JOURNAL OF IMMUNOLOGY (2006)
Human T regulatory cells can use the perforin pathway to cause autologous target cell death
WJ Grossman et al.
IMMUNITY (2004)
Share Paper
